Effect of canakinumab on clinical and biochemical parameters in acute gouty arthritis: a meta-analysis.
Monalisa JenaAmruta TripathyArchana MishraRituparna MaitiPublished in: Inflammopharmacology (2020)
This meta-analysis shows the beneficial effect of canakinumab over triamcinolone by reducing VAS score, serum hsCRP, serum amyloid A, and improvement in global assessments in acute gouty arthritis.